InsidersTradesSigma
Follow the Targeted Medical Pharma, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €301. The latest transaction was reported on 4 February 2016 (Attribution). Among the most active insiders: Wenkart Thomas Richard. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Targeted Medical Pharma, Inc. is a company focused on developing targeted medical treatments. It is listed on the XNAS market.